Synergic effect of Eicosapentaenoic acid and Lovastatin on gene expression of HMGCoA reductase and LDL receptor in cultured HepG2 cells

BACKGROUND: PUFAs are potent inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, an enzyme catalyzing the conversion of HMGCoA to mevalonate, the rate limiting step in cholesterol biosynthesis. Statins represent a class of drugs that are widely used to treat hypercholesterolemia...

Descripción completa

Detalles Bibliográficos
Autores principales: Notarnicola, Maria, Messa, Caterina, Refolo, Maria G, Tutino, Valeria, Miccolis, Angelica, Caruso, Maria G
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001710/
https://www.ncbi.nlm.nih.gov/pubmed/21118482
http://dx.doi.org/10.1186/1476-511X-9-135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001710/
https://www.ncbi.nlm.nih.gov/pubmed/21118482
http://dx.doi.org/10.1186/1476-511X-9-135

Ejemplares similares